SIP1 mediates cell-fate decisions between neuroectoderm and mesendoderm in human pluripotent stem cells.

PubWeight™: 1.21‹?› | Rank: Top 10%

🔗 View Article (PMID 20074535)

Published in Cell Stem Cell on January 08, 2010

Authors

Zhenzhi Chng1, Adrian Teo, Roger A Pedersen, Ludovic Vallier

Author Affiliations

1: Laboratory for Regenerative Medicine, West Forvie Building, Robinson Way, University of Cambridge, Cambridge, CB2 0SZ, UK.

Articles citing this

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene (2010) 9.66

The cell-cycle state of stem cells determines cell fate propensity. Cell (2013) 3.50

Pluripotency factors regulate definitive endoderm specification through eomesodermin. Genes Dev (2011) 2.22

The harmonies played by TGF-β in stem cell biology. Cell Stem Cell (2012) 1.47

Rapid and efficient differentiation of human pluripotent stem cells into intermediate mesoderm that forms tubules expressing kidney proximal tubular markers. J Am Soc Nephrol (2013) 1.38

Hematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells. Blood (2013) 1.14

Snail and the microRNA-200 family act in opposition to regulate epithelial-to-mesenchymal transition and germ layer fate restriction in differentiating ESCs. Stem Cells (2011) 1.11

Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage. Mol Ther (2010) 1.09

The zinc finger transcription factor Ovol2 acts downstream of the bone morphogenetic protein pathway to regulate the cell fate decision between neuroectoderm and mesendoderm. J Biol Chem (2013) 1.03

SMAD7 directly converts human embryonic stem cells to telencephalic fate by a default mechanism. Stem Cells (2013) 0.98

BMP and TGF-β pathway mediators are critical upstream regulators of Wnt signaling during midbrain dopamine differentiation in human pluripotent stem cells. Dev Biol (2013) 0.95

High-throughput fingerprinting of human pluripotent stem cell fate responses and lineage bias. Nat Methods (2013) 0.94

OVOL guides the epithelial-hybrid-mesenchymal transition. Oncotarget (2015) 0.93

miR-200 and miR-96 families repress neural induction from human embryonic stem cells. Development (2013) 0.88

Population based model of human embryonic stem cell (hESC) differentiation during endoderm induction. PLoS One (2012) 0.87

On becoming neural: what the embryo can tell us about differentiating neural stem cells. Am J Stem Cells (2013) 0.86

Potential for pharmacological manipulation of human embryonic stem cells. Br J Pharmacol (2013) 0.85

Dedifferentiation of foetal CNS stem cells to mesendoderm-like cells through an EMT process. PLoS One (2012) 0.80

Polycomb determines responses to smad2/3 signaling in embryonic stem cell differentiation and in reprogramming. Stem Cells (2013) 0.79

Neural transcription factors: from embryos to neural stem cells. Mol Cells (2014) 0.78

Four amino acids within a tandem QxVx repeat in a predicted extended α-helix of the Smad-binding domain of Sip1 are necessary for binding to activated Smad proteins. PLoS One (2013) 0.78

Epithelial-Mesenchymal Transition (EMT): A Biological Process in the Development, Stem Cell Differentiation and Tumorigenesis. J Cell Physiol (2017) 0.78

Pluripotent stem cell studies elucidate the underlying mechanisms of early embryonic development. Genes (Basel) (2011) 0.76

Looking into the black box: insights into the mechanisms of somatic cell reprogramming. Genes (Basel) (2011) 0.76

MSX2 mediates entry of human pluripotent stem cells into mesendoderm by simultaneously suppressing SOX2 and activating NODAL signaling. Cell Res (2015) 0.75

Zeb2 Regulates Cell Fate at the Exit from Epiblast State in Mouse Embryonic Stem Cells. Stem Cells (2016) 0.75

Articles by these authors

Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature (2007) 11.72

Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature (2011) 4.92

Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci (2005) 4.86

Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev (2009) 4.69

Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest (2010) 3.91

Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet (2005) 3.73

The cell-cycle state of stem cells determines cell fate propensity. Cell (2013) 3.50

Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology (2010) 3.16

Activin/Nodal signalling maintains pluripotency by controlling Nanog expression. Development (2009) 2.83

BRACHYURY and CDX2 mediate BMP-induced differentiation of human and mouse pluripotent stem cells into embryonic and extraembryonic lineages. Cell Stem Cell (2011) 2.79

Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway. Dev Biol (2004) 2.57

Inhibition of Activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm. Dev Biol (2007) 2.46

Pluripotency factors regulate definitive endoderm specification through eomesodermin. Genes Dev (2011) 2.22

Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1-targeted integration. Stem Cells (2007) 2.20

Early cell fate decisions of human embryonic stem cells and mouse epiblast stem cells are controlled by the same signalling pathways. PLoS One (2009) 2.18

Recombination signatures distinguish embryonic stem cells derived by parthenogenesis and somatic cell nuclear transfer. Cell Stem Cell (2007) 2.14

Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells. Stem Cells (2009) 1.96

Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility. Nat Biotechnol (2012) 1.94

Epigenetic status of human embryonic stem cells. Nat Genet (2005) 1.64

Status of genomic imprinting in human embryonic stem cells as revealed by a large cohort of independently derived and maintained lines. Hum Mol Genet (2007) 1.55

Activin/Nodal signaling controls divergent transcriptional networks in human embryonic stem cells and in endoderm progenitors. Stem Cells (2011) 1.51

Differentiation of trophoblast cells from human embryonic stem cells: to be or not to be? Reproduction (2014) 1.49

Human pre-implantation embryo development. Development (2012) 1.44

Production of hepatocyte-like cells from human pluripotent stem cells. Nat Protoc (2013) 1.44

Transplantation of expanded fetal intestinal progenitors contributes to colon regeneration after injury. Cell Stem Cell (2013) 1.39

Stem cell medicine encounters the immune system. Nat Rev Immunol (2002) 1.34

HOXB4 overexpression promotes hematopoietic development by human embryonic stem cells. Stem Cells (2006) 1.14

Emerging use of stem cells in regenerative medicine. Biochem J (2010) 1.14

Pleiotrophin enhances clonal growth and long-term expansion of human embryonic stem cells. Stem Cells (2007) 1.12

Enhancing and diminishing gene function in human embryonic stem cells. Stem Cells (2004) 1.07

Generation of multipotent foregut stem cells from human pluripotent stem cells. Stem Cell Reports (2013) 1.05

Conversion from mouse embryonic to extra-embryonic endoderm stem cells reveals distinct differentiation capacities of pluripotent stem cell states. Development (2012) 1.04

Real-time PCR mapping of DNaseI-hypersensitive sites using a novel ligation-mediated amplification technique. Nucleic Acids Res (2007) 1.03

Human embryonic stem cells: an in vitro model to study mechanisms controlling pluripotency in early mammalian development. Stem Cell Rev (2005) 1.02

Embryonic stem cell therapy for diabetes mellitus. Semin Cell Dev Biol (2007) 0.99

Overexpression of Nodal promotes differentiation of mouse embryonic stem cells into mesoderm and endoderm at the expense of neuroectoderm formation. Stem Cells Dev (2005) 0.98

Genomic targets of Brachyury (T) in differentiating mouse embryonic stem cells. PLoS One (2012) 0.96

A practical and efficient cellular substrate for the generation of induced pluripotent stem cells from adults: blood-derived endothelial progenitor cells. Stem Cells Transl Med (2012) 0.95

Nuclear transfer-derived epiblast stem cells are transcriptionally and epigenetically distinguishable from their fertilized-derived counterparts. Stem Cells (2010) 0.93

Biphasic induction of Pdx1 in mouse and human embryonic stem cells can mimic development of pancreatic beta-cells. Stem Cells (2009) 0.93

Human pluripotent stem cells for modelling human liver diseases and cell therapy. Curr Gene Ther (2013) 0.90

The serpinopathies studying serpin polymerization in vivo. Methods Enzymol (2011) 0.89

Status of genomic imprinting in epigenetically distinct pluripotent stem cells. Stem Cells (2012) 0.87

Induced pluripotent stem cells--alchemist's tale or clinical reality? Expert Rev Mol Med (2010) 0.87

Human embryonic stem cells as a model for studying epigenetic regulation during early development. Cell Cycle (2005) 0.85

Mouse pluripotent stem cells at a glance. J Cell Sci (2011) 0.84

Multiple roles of Activin/Nodal, bone morphogenetic protein, fibroblast growth factor and Wnt/β-catenin signalling in the anterior neural patterning of adherent human embryonic stem cell cultures. Open Biol (2013) 0.83

Poor development of human nuclear transfer embryos using failed fertilized oocytes. Reprod Biomed Online (2005) 0.81

Integration-deficient lentivectors: an effective strategy to purify and differentiate human embryonic stem cell-derived hepatic progenitors. BMC Biol (2013) 0.80

Pancreatic transcription factors containing protein transduction domains drive mouse embryonic stem cells towards endocrine pancreas. PLoS One (2012) 0.79

Survival and differentiation of adenovirus-generated induced pluripotent stem cells transplanted into the rat striatum. Cell Transplant (2013) 0.79

Distinct activities of the anaphase-promoting complex/cyclosome (APC/C) in mouse embryonic cells. Cell Cycle (2012) 0.79

Activin/nodal signaling and pluripotency. Vitam Horm (2011) 0.78

Navigating the pathway from embryonic stem cells to beta cells. Semin Cell Dev Biol (2004) 0.78

[Robust differentiation of fetal hepatocytes from human embryonic stem cells and iPS]. Med Sci (Paris) (2010) 0.78

CENP-B is not critical for meiotic chromosome segregation in male mice. Mutat Res (2002) 0.77

Aneuploidy involving chromosome 1 in failed-fertilized human oocytes is unrelated to maternal age. J Assist Reprod Genet (2005) 0.77

Autocrine and paracrine mechanisms regulating primordial germ cell proliferation. Mol Reprod Dev (2004) 0.75

Human stem cells for craniomaxillofacial reconstruction. Stem Cells Dev (2014) 0.75

Epigenetic Interactions and Gene Expression in Peri-Implantation Mouse Embryo Development. Mod Cell Biol (1) 0.75

Feeding hungry stem cells. Nat Biotechnol (2002) 0.75

Fucci2a mouse upgrades live cell cycle imaging. Cell Cycle (2015) 0.75

A factor(s) secreted from MIN-6 beta-cells stimulates differentiation of definitive endoderm enriched embryonic stem cells towards a pancreatic lineage. Mol Cell Endocrinol (2010) 0.75

Erratum: Genome editing reveals a role for OCT4 in human embryogenesis. Nature (2017) 0.75

Robust derivation of epicardium and its differentiated smooth muscle cell progeny from human pluripotent stem cells. Development (2016) 0.75

The Cell-Cycle State of Stem Cells Determines Cell Fate Propensity. Cell (2014) 0.75

Generation of Hepatocytes from Pluripotent Stem Cells for Drug Screening and Developmental Modeling. Methods Mol Biol (2015) 0.75

An important role of endothelial hairy-related transcription factors in mouse vascular development. Genesis (2014) 0.75

Corrigendum: Common genetic variation drives molecular heterogeneity in human iPSCs. Nature (2017) 0.75

Roles of H3K27me2 and H3K27me3 Examined during Fate Specification of Embryonic Stem Cells. Cell Rep (2017) 0.75

Corrigendum: Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programming. Nat Commun (2017) 0.75